| Article

The American Heart Association has issued a scientific statement calling for education for clinicians on the health implications of cannabis products. They are calling for funding and clinical trials, both of which are predicated on the removal of legal hurdles. The AHA states, “Our understanding of...

| Article

Newswise — Medical cannabis is finally being put under the microscope, in a first-of-its-kind real world evidence study led by Dr. Hance Clarke, Director of Pain Services, Toronto General Hospital, and a recognized leader in educating Canadians about chronic pain management and the risk factors of...

| Article

From the European Journal of Pain.

Background: Precise cannabis treatment dosing remains a major challenge, leading to physicians’ reluctance to prescribe medical cannabis.

Objective: To test the pharmacokinetics, analgesic effect, cognitive performance and safety effects of an innovative...

| Video

The prescribing of chronic opioid therapy to patients who contemplate or are already using marijuana, whether medical or recreational, sets up the perfect storm for medical decision-making and risk management conundrums, especially in the current environment of opioid related hospital admissions and...

| Article

Newswise — More than 90% of the legal marijuana products offered in medical dispensaries are much stronger than what clinical studies have shown that doctors recommend for chronic pain relief, according to a study published in the March 26 online edition of the journal PLOS ONE.

To many that...

| Video

Despite the widespread acceptance of medicinal and recreational cannabis use internationally and domestically, marijuana remains federally illegal in the United States. For this reason, there are significant legal implications to clinical practice. But what about endocannabinoid deficiency syndrome...

| Article

Newswise — McMaster University researchers have identified an antibacterial compound made by cannabis plants that may serve as a lead for new drug development.

An interdisciplinary team of McMaster researchers found that the chemical compound, or cannabinoid, called cannabigerol (CBG) is not only...

| Article

Newswise — Residents of states where cannabis has been legalized are more likely to believe it has beneficial effects - including health benefits in treatment of pain and anxiety or depression, reports a survey study in the Journal of Addiction Medicine, the official journal of the American Society...

| Article

Newswise — A team of researchers at the University of Georgia will study how legalized medical cannabis affects people living with chronic pain.

To date, 34 states and the District of Columbia have adopted medical cannabis laws, or MCLs, which legalize either home cultivation or dispensary-based...

| Article

Newswise — Using the largest database of real-time recordings of the effects of common and commercially available cannabis products in the United States (U.S.), researchers at The University of New Mexico (UNM) found strong evidence that cannabis can significantly alleviate pain, with the average...

Subscribe to medical cannabinoids

Sign-Up